Enterprise Financial Services Corp Agenus Inc Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$2.41 - $4.4 $400 - $730	-166 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$2.17 - $3.14 $360 - $521	166 New	166 $0
Q2 2019 Jul 30, 2019	SELL	$2.53 - $3.04 $419 - $504	-166 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$2.51 - $3.73 $416 - $619	166 New	166 $0

1.99M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.